Drug Type Monoclonal antibody |
Synonyms- |
Target |
Mechanism VPREB1 antagonists(V-set pre-B cell surrogate light chain 1 antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Acute Lymphoblastic Leukemia | Preclinical | US | 20 Sep 2017 |